Skip to content

GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis

GO2 PEEP Study: The Use of a Bidirectional Oxygenation Valve in the Prevention and Management of Postoperative Atelectasis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04253834
Enrollment
20
Registered
2020-02-05
Start date
2020-08-27
Completion date
2021-01-31
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Atelectasis

Keywords

Cardiac surgery, Coronary bypass, Heart valve replacement, Postoperative pulmonary complications

Brief summary

This study compares a novel breathing device, called the GO2 Mouthpiece, to the standard breathing tool called the incentive spirometer, thus improving respiratory dynamics of the postoperative patient.

Detailed description

Postoperative pulmonary complications (PPCs) are the principal cause of morbidity, mortality and prolonged hospitalizations in surgical patients, which results in a 50% increase in healthcare costs compared to postoperative cardiac complications. This is especially evident following cardiovascular surgery. One of the most common PPCs is atelectasis, resulting in dyspnea, tachypnea and hypoxemia. Postoperative atelectasis is a predictable consequence of anesthesia, surgical trauma, and pain associated with breathing. Methods aimed at increasing lung volume and treating atelectasis, commonly known as postoperative physiotherapy, play an important role in preventing PPCs. These methods include cough and deep breathing, continuous positive airway pressure (CPAP), postural drainage, incentive spirometry and positive end expiratory pressure (PEEP). Incentive spirometry has served as a convenient approach for the postoperative patient to sustain maximal inflations and encourage deep breathing. Although incentive spirometry is used commonly by post-operative patients, evidence fails to support its benefit. PEEP is a well-known pulmonary physiologic principle. There are on average 600 million alveoli in the lung. Each alveolus has surfactant to resist the natural propensity for these small air sacs to collapse during exhalation. Despite this surfactant, some alveoli will collapse and not be available for gas exchange. This atelectasis results in a ventilation/perfusion mismatch where alveolar units are perfused but not adequately ventilated. This is referred to as shunting and results in hypoxemia (decreased PaO2). PEEP decreases the propensity for the alveoli to collapse by increasing the air pressure in the lungs. This residual pressure in the lungs at the end of exhalation decreases shunting and allows for more complete gas exchange and improved oxygenation. In patients, PEEP is one of the safest ways to increase PaO2 and is used on almost all modern ventilator settings. The purpose of this study is to compare a novel breathing device, called the GO2 Mouthpiece, which uses the concept of PEEP, to the incentive spirometer in postoperative patients.

Interventions

The incentive spirometer is a device that measures how deeply a person can inhale (breathe in). It helps with taking slow, deep breaths to expand and fill the lungs with air, which helps prevent lung problems, such as pneumonia. The incentive spirometer is made up of a breathing tube, an air chamber, and an indicator to help users control their breathing.

DEVICEGO2 Mouthpiece

The GO2 Mouthpiece is a simple, comfortable, and straightforward silicone rubber-made, bidirectional oxygenation mouthpiece that effectively delivers PEEP with every breath.

Sponsors

PEEP Medical, LLC
CollaboratorINDUSTRY
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Single center, prospective, randomized controlled study

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Undergoing coronary artery bypass surgery (CABG) and/or valve replacement surgery 2. Able to provide written informed consent 3. Maintenance of an arterial line postoperatively

Exclusion criteria

1. Active smoking, within three months of surgery 2. Forced expiratory volume in one second (FEV1) \<75% predicted 3. Relative risk to develop pulmonary barotrauma as evident by history of pneumothorax or emphysema 4. Unable or unwilling to provide informed consent, cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Partial Pressure of Oxygen (PaO2 Level)1, 6, 12 and 24 hours postextubationPartial pressure of oxygen is a measurement of oxygen pressure in arterial blood. It reflects how well oxygen is able to move from the lungs to the blood. Normal values are 80 to 100 millimeters of mercury (mmHg).

Secondary

MeasureTime frameDescription
Number of Participants With Normal Atelectasis ScoreImmediately postoperative, Postoperative days 1, 2, 3, 4Atelectasis is a lung condition that happens when the airways don't expand normally. Atelectasis is measured with the modified radiological atelectasis score (m-RAS). Each pulmonary lobe, including the lingula, is scored 0-3 (0=normal, 1=plate or minor infiltrate, 2= moderate atelectasis, 3= total atelectasis). The scores of the six lobes are then summed to give a total score ranging from 0 to 18 with higher scores being associated with worse outcomes. For this analysis, scores were categorized as 0 (normal) or greater than 0 (not normal). The count of participants with a normal atelectasis score at the indicated time point are presented here.
Oxygen RequirementPostextubation Hours 1, 6, 12 and 24, Postoperative Days 2, 3, and 4Oxygen was provided by a nasal cannula. The flow rate of supplemental oxygen that participants required after surgery is assessed as liters per minute. Higher flow rate indicates an increased need for supplemental oxygen.
Carbon Dioxide LevelPostextubation Hours 1, 6, 12 and 24Normal carbon dioxide (CO2) levels in blood range from 35.0 mmHg to 45.0 mmHg.
FEV1Preoperative and postoperative day 3Forced expiratory volume in one second (FEV1) is measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine. FEV1 is the amount of air forced from lungs in one second. To describe severity of pulmonary disease, FEV1 can be expressed as a percentage of the predicted value. Values 80% and and greater of the predicted value are considered normal.
Forced Vital Capacity (FVC)Preoperative, Postoperative Day 3Forced vital capacity (FVC) is measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine. FVC is the total amount of air exhaled during the FEV test. FVC can be expressed as a percentage of the predicted value.The normal range for the percent of the predicted value is between 80% and 120%.
Respiratory RatePostextubation Hours 1, 6, 12 and 24, Postoperative Days 2, 3, and 4Respiratory rate is the number of breaths taken per minute. The normal respiration rate for an adult at rest is 16 to 20 breaths per minute.
Body TemperatureImmediately Postoperative, Postoperative Day 1, 2, 3, 4Measure of heat associated with the metabolism of the body. Normal range is between 36.5-37.5 degrees Celsius (°C).

Countries

United States

Participant flow

Recruitment details

Participant enrollment began August 27, 2020 and all study follow up was completed January 31, 2021. Participants were enrolled at Emory Saint Joseph's Hospital in Atlanta, Georgia, USA.

Participants by arm

ArmCount
Incentive Spirometer Control Arm
Participants using the incentive spirometer after surgery.
10
GO2 Mouthpiece
Participants using the GO2 Mouthpiece after surgery.
10
Total20

Baseline characteristics

CharacteristicIncentive Spirometer Control ArmGO2 MouthpieceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants6 Participants10 Participants
Age, Categorical
Between 18 and 65 years
6 Participants4 Participants10 Participants
Age, Continuous65.1 years
STANDARD_DEVIATION 8.7
67.1 years
STANDARD_DEVIATION 6.9
66.1 years
STANDARD_DEVIATION 7.7
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants10 Participants18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants1 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants9 Participants17 Participants
Region of Enrollment
United States
10 Participants10 Participants20 Participants
Sex: Female, Male
Female
2 Participants0 Participants2 Participants
Sex: Female, Male
Male
8 Participants10 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
1 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Partial Pressure of Oxygen (PaO2 Level)

Partial pressure of oxygen is a measurement of oxygen pressure in arterial blood. It reflects how well oxygen is able to move from the lungs to the blood. Normal values are 80 to 100 millimeters of mercury (mmHg).

Time frame: 1, 6, 12 and 24 hours postextubation

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmPartial Pressure of Oxygen (PaO2 Level)1 hour postextubation95.4 mmHgStandard Deviation 22.6
Incentive Spirometer Control ArmPartial Pressure of Oxygen (PaO2 Level)6 hours postextubation92.1 mmHgStandard Deviation 28.1
Incentive Spirometer Control ArmPartial Pressure of Oxygen (PaO2 Level)12 hours postextubation91.0 mmHgStandard Deviation 21.8
Incentive Spirometer Control ArmPartial Pressure of Oxygen (PaO2 Level)24 hours postextubation74.5 mmHgStandard Deviation 17.2
GO2 MouthpiecePartial Pressure of Oxygen (PaO2 Level)24 hours postextubation77.8 mmHgStandard Deviation 14.6
GO2 MouthpiecePartial Pressure of Oxygen (PaO2 Level)1 hour postextubation83.5 mmHgStandard Deviation 18.3
GO2 MouthpiecePartial Pressure of Oxygen (PaO2 Level)12 hours postextubation81.4 mmHgStandard Deviation 17.9
GO2 MouthpiecePartial Pressure of Oxygen (PaO2 Level)6 hours postextubation85.4 mmHgStandard Deviation 22.3
Secondary

Body Temperature

Measure of heat associated with the metabolism of the body. Normal range is between 36.5-37.5 degrees Celsius (°C).

Time frame: Immediately Postoperative, Postoperative Day 1, 2, 3, 4

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmBody TemperaturePostoperative Day 138.0 °CStandard Deviation 1.4
Incentive Spirometer Control ArmBody TemperaturePostoperative Day 337.3 °CStandard Deviation 0.3
Incentive Spirometer Control ArmBody TemperaturePostoperative Day 237.5 °CStandard Deviation 0.4
Incentive Spirometer Control ArmBody TemperaturePostoperative Day 437.2 °CStandard Deviation 0.2
Incentive Spirometer Control ArmBody TemperaturePostoperative36.8 °CStandard Deviation 0.2
GO2 MouthpieceBody TemperaturePostoperative Day 437.2 °CStandard Deviation 0.2
GO2 MouthpieceBody TemperaturePostoperative36.8 °CStandard Deviation 0.3
GO2 MouthpieceBody TemperaturePostoperative Day 137.7 °CStandard Deviation 0.4
GO2 MouthpieceBody TemperaturePostoperative Day 237.4 °CStandard Deviation 0.3
GO2 MouthpieceBody TemperaturePostoperative Day 337.4 °CStandard Deviation 0.3
Secondary

Carbon Dioxide Level

Normal carbon dioxide (CO2) levels in blood range from 35.0 mmHg to 45.0 mmHg.

Time frame: Postextubation Hours 1, 6, 12 and 24

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmCarbon Dioxide LevelPostextubation Hour 138.2 mmHgStandard Deviation 2.9
Incentive Spirometer Control ArmCarbon Dioxide LevelPostextubation Hour 637.0 mmHgStandard Deviation 4.8
Incentive Spirometer Control ArmCarbon Dioxide LevelPostextubation Hour 1237.3 mmHgStandard Deviation 5.1
Incentive Spirometer Control ArmCarbon Dioxide LevelPostextubation Hour 2436.8 mmHgStandard Deviation 5.1
GO2 MouthpieceCarbon Dioxide LevelPostextubation Hour 2438.1 mmHgStandard Deviation 3.8
GO2 MouthpieceCarbon Dioxide LevelPostextubation Hour 139 mmHgStandard Deviation 3.3
GO2 MouthpieceCarbon Dioxide LevelPostextubation Hour 1236.9 mmHgStandard Deviation 4.2
GO2 MouthpieceCarbon Dioxide LevelPostextubation Hour 637.2 mmHgStandard Deviation 4.4
Secondary

FEV1

Forced expiratory volume in one second (FEV1) is measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine. FEV1 is the amount of air forced from lungs in one second. To describe severity of pulmonary disease, FEV1 can be expressed as a percentage of the predicted value. Values 80% and and greater of the predicted value are considered normal.

Time frame: Preoperative and postoperative day 3

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmFEV1Preoperative86.4 percentage of the predicted FEV1 valueStandard Deviation 10.1
Incentive Spirometer Control ArmFEV1Postoperative Day 335.9 percentage of the predicted FEV1 valueStandard Deviation 8
GO2 MouthpieceFEV1Preoperative93.7 percentage of the predicted FEV1 valueStandard Deviation 8.9
GO2 MouthpieceFEV1Postoperative Day 343.1 percentage of the predicted FEV1 valueStandard Deviation 10.7
Secondary

Forced Vital Capacity (FVC)

Forced vital capacity (FVC) is measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine. FVC is the total amount of air exhaled during the FEV test. FVC can be expressed as a percentage of the predicted value.The normal range for the percent of the predicted value is between 80% and 120%.

Time frame: Preoperative, Postoperative Day 3

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmForced Vital Capacity (FVC)Preoperative85.7 percentage of the predicted FVC valueStandard Deviation 9.8
Incentive Spirometer Control ArmForced Vital Capacity (FVC)Postoperative Day 338.0 percentage of the predicted FVC valueStandard Deviation 9.9
GO2 MouthpieceForced Vital Capacity (FVC)Preoperative90.1 percentage of the predicted FVC valueStandard Deviation 8.3
GO2 MouthpieceForced Vital Capacity (FVC)Postoperative Day 341.6 percentage of the predicted FVC valueStandard Deviation 10.5
Secondary

Number of Participants With Normal Atelectasis Score

Atelectasis is a lung condition that happens when the airways don't expand normally. Atelectasis is measured with the modified radiological atelectasis score (m-RAS). Each pulmonary lobe, including the lingula, is scored 0-3 (0=normal, 1=plate or minor infiltrate, 2= moderate atelectasis, 3= total atelectasis). The scores of the six lobes are then summed to give a total score ranging from 0 to 18 with higher scores being associated with worse outcomes. For this analysis, scores were categorized as 0 (normal) or greater than 0 (not normal). The count of participants with a normal atelectasis score at the indicated time point are presented here.

Time frame: Immediately postoperative, Postoperative days 1, 2, 3, 4

Population: This analysis includes participants who completed the chest x-ray at the indicated visits. The atelectasis score could not be determined for one participant at postoperative day 3 and two participants at postoperative day 4 because chest x-rays were not performed.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Incentive Spirometer Control ArmNumber of Participants With Normal Atelectasis ScorePostoperative Day 10 Participants
Incentive Spirometer Control ArmNumber of Participants With Normal Atelectasis ScorePostoperative Day 30 Participants
Incentive Spirometer Control ArmNumber of Participants With Normal Atelectasis ScorePostoperative Day 20 Participants
Incentive Spirometer Control ArmNumber of Participants With Normal Atelectasis ScorePostoperative Day 42 Participants
Incentive Spirometer Control ArmNumber of Participants With Normal Atelectasis ScoreImmediately Postoperative0 Participants
GO2 MouthpieceNumber of Participants With Normal Atelectasis ScorePostoperative Day 40 Participants
GO2 MouthpieceNumber of Participants With Normal Atelectasis ScoreImmediately Postoperative2 Participants
GO2 MouthpieceNumber of Participants With Normal Atelectasis ScorePostoperative Day 10 Participants
GO2 MouthpieceNumber of Participants With Normal Atelectasis ScorePostoperative Day 20 Participants
GO2 MouthpieceNumber of Participants With Normal Atelectasis ScorePostoperative Day 30 Participants
Secondary

Oxygen Requirement

Oxygen was provided by a nasal cannula. The flow rate of supplemental oxygen that participants required after surgery is assessed as liters per minute. Higher flow rate indicates an increased need for supplemental oxygen.

Time frame: Postextubation Hours 1, 6, 12 and 24, Postoperative Days 2, 3, and 4

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmOxygen RequirementPostextubation Hour 242.4 liters of oxygen per minuteStandard Deviation 2.8
Incentive Spirometer Control ArmOxygen RequirementPostextubation Hour 13.7 liters of oxygen per minuteStandard Deviation 1.26
Incentive Spirometer Control ArmOxygen RequirementPostoperative Day 22.0 liters of oxygen per minuteStandard Deviation 1.6
Incentive Spirometer Control ArmOxygen RequirementPostextubation Hour 122.2 liters of oxygen per minuteStandard Deviation 1.5
Incentive Spirometer Control ArmOxygen RequirementPostoperative Day 31.1 liters of oxygen per minuteStandard Deviation 1.2
Incentive Spirometer Control ArmOxygen RequirementPostoperative Day 40.6 liters of oxygen per minuteStandard Deviation 1
Incentive Spirometer Control ArmOxygen RequirementPostextubation Hour 62.3 liters of oxygen per minuteStandard Deviation 0.7
GO2 MouthpieceOxygen RequirementPostoperative Day 40.5 liters of oxygen per minuteStandard Deviation 1.1
GO2 MouthpieceOxygen RequirementPostextubation Hour 13.7 liters of oxygen per minuteStandard Deviation 1.7
GO2 MouthpieceOxygen RequirementPostextubation Hour 62.4 liters of oxygen per minuteStandard Deviation 0.8
GO2 MouthpieceOxygen RequirementPostextubation Hour 122.1 liters of oxygen per minuteStandard Deviation 0.3
GO2 MouthpieceOxygen RequirementPostextubation Hour 242.3 liters of oxygen per minuteStandard Deviation 0.7
GO2 MouthpieceOxygen RequirementPostoperative Day 22.3 liters of oxygen per minuteStandard Deviation 1.1
GO2 MouthpieceOxygen RequirementPostoperative Day 31.7 liters of oxygen per minuteStandard Deviation 0.9
Secondary

Respiratory Rate

Respiratory rate is the number of breaths taken per minute. The normal respiration rate for an adult at rest is 16 to 20 breaths per minute.

Time frame: Postextubation Hours 1, 6, 12 and 24, Postoperative Days 2, 3, and 4

ArmMeasureGroupValue (MEAN)Dispersion
Incentive Spirometer Control ArmRespiratory RatePostextubation Hour 621.2 breaths per minuteStandard Deviation 5.5
Incentive Spirometer Control ArmRespiratory RatePostextubation Hour 2420.7 breaths per minuteStandard Deviation 3.8
Incentive Spirometer Control ArmRespiratory RatePostextubation Hour 121.3 breaths per minuteStandard Deviation 4
Incentive Spirometer Control ArmRespiratory RatePostoperative Day 221.7 breaths per minuteStandard Deviation 4.9
Incentive Spirometer Control ArmRespiratory RatePostextubation Hour 1221.0 breaths per minuteStandard Deviation 3.9
Incentive Spirometer Control ArmRespiratory RatePostoperative Day 318.4 breaths per minuteStandard Deviation 1.3
Incentive Spirometer Control ArmRespiratory RatePostoperative Day 418.0 breaths per minuteStandard Deviation 1.7
GO2 MouthpieceRespiratory RatePostextubation Hour 1219.2 breaths per minuteStandard Deviation 3.3
GO2 MouthpieceRespiratory RatePostoperative Day 318.4 breaths per minuteStandard Deviation 1.3
GO2 MouthpieceRespiratory RatePostextubation Hour 120.5 breaths per minuteStandard Deviation 5.8
GO2 MouthpieceRespiratory RatePostextubation Hour 617.9 breaths per minuteStandard Deviation 4.8
GO2 MouthpieceRespiratory RatePostoperative Day 418.6 breaths per minuteStandard Deviation 1.3
GO2 MouthpieceRespiratory RatePostextubation Hour 2418.9 breaths per minuteStandard Deviation 3.2
GO2 MouthpieceRespiratory RatePostoperative Day 220.6 breaths per minuteStandard Deviation 3.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026